Aquestive Therapeutics Inc. (AQST) Misses Q1 EPS by 8c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.24), $0.08 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $12.23 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• MARA amends Texas power site purchase agreement, posts $100M deposit
• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030